- Home
- CMPX vs SANG Comparison
CMPX vs SANG Comparison
Compare CMPX & SANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- SANG
- Stock Information
- Founded
- CMPX 2014
- SANG 1984
- Country
- CMPX United States
- SANG Canada
- Employees
- CMPX N/A
- SANG N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- SANG Computer Software: Programming Data Processing
- Sector
- CMPX Health Care
- SANG Technology
- Exchange
- CMPX Nasdaq
- SANG Nasdaq
- Market Cap
- CMPX 217.4M
- SANG 170.7M
- IPO Year
- CMPX N/A
- SANG 2021
- Fundamental
- Price
- CMPX $1.68
- SANG $6.04
- Analyst Decision
- CMPX Strong Buy
- SANG Buy
- Analyst Count
- CMPX 3
- SANG 2
- Target Price
- CMPX $7.67
- SANG $5.63
- AVG Volume (30 Days)
- CMPX 401.9K
- SANG 4.3K
- Earning Date
- CMPX 11-07-2024
- SANG 11-06-2024
- Dividend Yield
- CMPX N/A
- SANG N/A
- EPS Growth
- CMPX N/A
- SANG N/A
- EPS
- CMPX N/A
- SANG N/A
- Revenue
- CMPX $850,000.00
- SANG $250,030,000.00
- Revenue This Year
- CMPX N/A
- SANG N/A
- Revenue Next Year
- CMPX $950.68
- SANG $3.05
- P/E Ratio
- CMPX N/A
- SANG N/A
- Revenue Growth
- CMPX N/A
- SANG N/A
- 52 Week Low
- CMPX $0.77
- SANG $2.18
- 52 Week High
- CMPX $2.34
- SANG $6.40
- Technical
- Relative Strength Index (RSI)
- CMPX 65.80
- SANG 66.02
- Support Level
- CMPX $1.42
- SANG $5.15
- Resistance Level
- CMPX $1.86
- SANG $5.50
- Average True Range (ATR)
- CMPX 0.14
- SANG 0.23
- MACD
- CMPX 0.02
- SANG 0.05
- Stochastic Oscillator
- CMPX 72.17
- SANG 74.60
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable Internet protocol communications systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes Cloud Services, Video Conferencing, Carrier Services, Business Phone Systems, Phones & Devices, and Network Connectivity. The company sells into three major geographic centers: the United States of America, which is the key revenue driver, Canada, and other foreign countries.